Boston, MA 10/03/2014 (wallstreetpr) – Shares of X T L Biopharmaceuticals Ltd (ADR) (NASDAQ:XTLB) moved up smartly by 104.85% to close at $3.38. It traded with volumes of 1.43 million which was 345 times more than the 30 days average volume of 4,140 shares. Shares spiked after company announced stellar set of numbers which showed that the loss for the quarter came down from $1 million to $723,000 for the quarter ending June 30, 2014. One important thing to note was increase in R&D expenses from $25,000 to $40,000 for clinical trial expenses. The company did save by reducing its General and administrative expenses from $694,000 to $488,000.
Shares of Qualstar Corporation (NASDAQ:QBAK) moved up smartly by 38.98% to close at $1.64. The company had reported earnings on 29th September. Notable factor among the earnings released by the company was decrease in Loss from operations which came at $0.7 million compared to loss of $3.5 million, something which was cheered by investors and traders. There was a marginal increase in revenues from Data storage segment which increased to $1.2 million compared to $1.1 million in previous quarter.
“Qualstar’s loyal resellers and new partners from around the world have shown their enthusiastic endorsement of the new and refreshed product lines and are experiencing first-hand the renewed vitality and vigor of Qualstar as we support and enable our channel partners to be successful,” stated Daniel K. Jan, Qualstar’s Executive Vice President.
Shares of GlobeImmune Inc (NASDAQ:GBIM) were up by whopping 36.69% to close at $10.73. The shares traded with volume of 73,837 compared to average volume of 13,328. Though there was no specific news as such for the company, However it moved up in line with other Healthcare stocks in the sector. One of the biggest gainers among healthcare stocks was X T L Biopharmaceuticals Ltd (ADR) (NASDAQ:XTLB) which led the sector with 104.85% gains. Confirmation of Ebola in US has created ripples across US and investors are trying to invest in safe havens stocks.
Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. While reading this article one must assume that we may be compensated for posting this content on our website.